Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pulmonary Infective Endocarditis.

Prieto-Arévalo R, Muñoz P, Cuerpo G, Marí-Hualde A, Castelo-Corral L, Navas-Elorza E, Cifuentes-Luna C, Alonso-Socas MDM, Boix-Palop L, Martínez-Sellés M; Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES).

J Am Coll Cardiol. 2019 Jun 4;73(21):2782-2784. doi: 10.1016/j.jacc.2019.03.480. No abstract available.

PMID:
31146824
2.

Assessment of Quality Indicators for Appropriate Antibiotic Use.

Arcenillas P, Boix-Palop L, Gómez L, Xercavins M, March P, Martinez L, Riera M, Madridejos R, Badia C, Nicolás J, Calbo E.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00875-18. doi: 10.1128/AAC.00875-18. Print 2018 Dec.

3.

Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.

Dietl B, Sánchez I, Arcenillas P, Cuchi E, Gómez L, González de Molina FJ, Boix-Palop L, Nicolás J, Calbo E.

Int J Antimicrob Agents. 2018 Mar;51(3):498-502. doi: 10.1016/j.ijantimicag.2017.11.003. Epub 2017 Nov 20.

PMID:
29158144
4.

Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.

Boix-Palop L, Xercavins M, Badía C, Obradors M, Riera M, Freixas N, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.

PMID:
28552471
5.

Bacillus species pseudo-outbreak: construction works and collateral damage.

Boix-Palop L, Nicolás C, Xercavins M, Riera M, Prim N, Freixas N, Pérez J, Calbo E.

J Hosp Infect. 2017 Jan;95(1):118-122. doi: 10.1016/j.jhin.2016.10.013. Epub 2016 Oct 24.

PMID:
27856013

Supplemental Content

Loading ...
Support Center